In a report released today, Steven Halper from Cantor Fitzgerald reiterated a Buy rating on Centene Corp (NYSE: CNC), with a price target of $125. The company’s shares closed yesterday at $115.49, close to its 52-week high of $117.86.
According to TipRanks.com, Halper is a 5-star analyst with an average return of 16.0% and a 66.8% success rate. Halper covers the Services sector, focusing on stocks such as WellCare Health Plans, Tivity Health Inc, and Hms Holdings Corp.
Currently, the analyst consensus on Centene Corp is Strong Buy and the average price target is $118.33, representing a 2.5% upside.
In a report issued on April 24, Oppenheimer also maintained a Buy rating on the stock with a $130 price target.
See today’s analyst top recommended stocks >>
Based on Centene Corp’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $13.19 billion and net profit of $340 million. In comparison, last year the company earned revenue of $11.72 billion and had a net profit of $139 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the Managed Care and Specialty Services segments. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid.
